EVERSANA | LinkedIn (original) (raw)

About us

EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.

Industry

Pharmaceutical Manufacturing

Company size

5,001-10,000 employees

Headquarters

Chicago, IL

Type

Privately Held

Specialties

Regulatory, Management & Specialty Consulting, Research & Insights, Global Pricing Strategies, Patient, Payer & Provider Marketing Services, Field Medical, Market Access & Sales , Global Channel Management & 3PL, Specialty Pharmacy & In-Home Nursing, HUB & Adherence Solutions, Affordability Programs, Medical Communications & Pharmacovigilance, Revenue Management, Digital Strategies & Therapy Transformation, Patient Analytics Services, Integrated Patient-Level Data, Commercial Analytics Platform, RWE & HEOR Global Services, Global Launch Expertise, and Payer Reimbursement Strategies

Locations

Primary
205 N Michigan Ave
3200
Chicago, IL 60601, US
Get directions
4550 S Mendenhall Rd
Memphis, Tennessee, US
Get directions
10877 Commerce Way
Fontana, California 92337, US
Get directions
17877 Chesterfield Airport Rd
Chesterfield, Missouri, US
Get directions
790 Township Line Road
Yardley, PA 19067, US
Get directions
101 Greenwich Street
10A
New York, NY 10018, US
Get directions
4225 Executive Sq
San Diego, California 92121, US
Get directions
8990 Duke Blvd
Mason, Ohio 45040, US
Get directions
204-3228 S Service Rd
Burlington, Ontario, CA
Get directions
Bengaluru, IN
Get directions
Dublin, IE
Get directions
6 Kean Street
5th Floor
London, WC2B 4AS, GB
Get directions
AP81, 83, N Main Rd, near Hard Rock Cafe
7th Floor, Mundhwa
Pune, Maharashtra 411036, IN
Get directions
Shanghai, CN
Get directions
Singapore, 059818, SG
Get directions
99 Summer Street
Suite 1600
Boston , MA 02120, US
Get directions
204, 2nd Floor, Winchester Building, One South Avenue, Hiranandani Gardens,
Mumbai, Powai 400076, IN
Get directions
7045 College Blvd
Overland Park, Kansas 66211, US
Get directions
219 Duffering Street
207B and 210B
Toronto, ON M6K3J1, CA
Get directions
2001 Lakeshore Dr
Mandeville, Louisiana 70448, US
Get directions
92 Congress Street
Saratoga Springs, NY 12866, US
Get directions
1207 Sanno Park Tower, 2-11-1 Nagatacho, Chiyoda-ku
Tokyo, 100-6112, JP
Get directions
B-301 3rd Floor B Wing Felxcel Park
S. V. Road next to 24 Karat Multiplex Jogeshwari (W)
Mumbai, Maharashtra 400102, IN
Get directions
Schinkelplatz 5
Berlin, BE 10117, DE
Get directions

Employees at EVERSANA

Updates

Accelerating time to diagnosis and therapy drives better patient outcomes. By harnessing #patientfinding, personalized engagement and an integrated telehealth platform, Direct-to-Patient (DTP) models can reduce wait times by 85%. Activate patients. Simplify onboarding. Improve outcomes. Discover more benefits of #DTP: https://ow.ly/U8Cs50Uq8Kc
This Martin Luther King Jr. Day, we remember the message of Dr. King’s 1957 sermon at Dexter Avenue Baptist Church in Montgomery, Alabama, which highlights the importance of service and community. Let's unite in creating positive change for all. Happy #MLKDay!
463,733 followers
1w Edited
With patients increasingly demanding convenience and transparency, Direct-to-Patient (DTP) models provide much-needed solutions by bridging gaps in access and simplifying complex health journeys. The result? Better outcomes for patients and more sustainable growth for healthcare stakeholders. DTP models create: - Accelerated Access: Virtual care and technology enable patients to connect with providers in days, not months. - Improved Support: Integrated solutions combine telehealth, affordability tools and educational resources to guide patients seamlessly from diagnosis to therapy. - Proven Outcomes: Significant reductions in patient acquisition costs and faster time-to-therapy, all while boosting adherence rates and enhancing patient satisfaction. Read this latest article from Gregory Skalicky, MBA and Faruk Abdullah to discover how DTP models are reshaping the future of healthcare: https://ow.ly/Nep650Uq7tC
Discover how the pandemic accelerated the adoption and innovation of point-of-care (POC) diagnostics, turning them into essential tools for modern healthcare. Our latest article explores the evolution of POC diagnostics, highlighting key categories such as POC rapids, immunoassays, and molecular diagnostics. Learn about their technological advancements, market growth, and the impact of major industry acquisitions. Dive into the post-pandemic landscape and see how POC diagnostics are integrating into broader healthcare ecosystems, including remote care and telemedicine. This is a must-read for anyone looking to stay ahead in the rapidly evolving world of healthcare diagnostics. Read the full POV document here: https://ow.ly/Zzmr50UBTHs #POCDiagnostics #GlobalHealth
Rare disease therapies often face hurdles in transitioning from clinical trials to commercialization. Manufacturers need a solution that ensures operational efficiency and continuity for patients. EVERANA supports a smooth transition while preserving patient trust and satisfaction. Our streamlined approach keeps therapies moving forward without interruptions. Explore how efficiency accelerates impact: https://ow.ly/22tQ50UsEEv
We are thrilled to announce that EVERSANA is participating in the upcoming webinar hosted by the Digital Therapeutics Alliance! Join us as we delve into the latest advancements in digital therapeutics and explore how these innovations are transforming healthcare. Don't miss this opportunity to gain valuable insights from industry leaders and experts. We look forward to engaging with you and discussing the future of digital health. Register here: https://lnkd.in/g6zrAg9B
Join us for a webinar series where we delve into the complexities of regulatory and reimbursement pathways for digital therapeutics around the globe. Each session in this series will focus on a specific country or region, providing a comprehensive overview of the landscape for digital therapeutics. In this session, we will focus on a specific the Asia-Pacific region, providing a comprehensive overview of the regulatory and reimbursement frameworks for digital therapeutics. We will review the frameworks in countries including South Korea, Japan, China, Singapore, and Australia. Register now: https://lnkd.in/g6zrAg9B Chungkeun Lee Grace Lethlean Nishit Patadia Roberta Sarno, PhD #DTAEvents #DTx #DigitalTherapeutics #DigitalTherapeuticsAlliance
This content isn’t available here
Access this content and more in the LinkedIn app
Metastatic castration-resistant prostate cancer (mCRPC) remains a challenging condition with limited therapeutic options and a low five-year survival rate. However, recent advancements in PARP inhibitors combined with androgen receptor pathway inhibitors offer new hope. Our Value & Evidence team, in collaboration with Pfizer Inc., conducted a matching-adjusted indirect comparison (MAIC) to evaluate these novel therapies. This study provides crucial insights into their relative efficacy, aiding clinical decision-making in the absence of direct comparative trials. Discover how this research can guide optimal treatment strategies for mCRPC patients. Read the full article in Prostate Cancer and Prostatic Diseases: https://ow.ly/NcT950UxVVE #ProstateCancer #mCRPC #PARPInhibitors #ClinicalResearchImtiaz Samjoo, Anja Haltner, Samantha Craigie, Di Wang , Sarah Walsh
EVERSANA reposted this
Patient acquisition doesn’t have to mean sky-high costs. A Direct-to-Patient (DTP) model helps pharma manufacturers: - Build a demand funnel with patient prediction and finding - Streamline onboarding through digital-first engagement - Augment traditional channels with a telehealth integration - Reduce investments with a ready-to-deploy model The result? Lower operating expenses without compromising patient reach and impact. Discover more benefits of #DTP: https://ow.ly/XqMB50Uq6Eo
463,733 followers
2w Edited
The rapid evolution of digital health policy is reshaping healthcare delivery and innovation. From advancements in AI-driven diagnostics to expanded reimbursement codes for digital therapeutics, 2024 was a transformative year. But what lies ahead for 2025? Our experts, Kory Dillman, Brian Abraham and Marty Culjat break down the modern landscape of digital health in this new article. Key insights include: • Updates to reimbursement codes for telehealth, remote monitoring, and digital therapeutics. • New opportunities for AI and wearable devices through regulatory advancements. • Predictions for 2025, including expanded CMS codes and critical FDA guidance on cybersecurity and AI. Discover how these shifts are paving the way for broader access, innovation and improved patient care. Read the full article here: https://ow.ly/rZX950UBRgP #DigitalHealth #HealthcareInnovation

EVERSANA | LinkedIn (original) (raw)

About us

Locations

Employees at EVERSANA

Updates

Join now to see what you are missing

Affiliated pages

Similar pages

Browse jobs

Funding